Posters

ASHG 2023

MedGenome’s genomics solutions for precision medicine

Kushal Suryamohan, Ravi Gupta, Marco Corbo, Ramesh Menon, Megha Muraleedharan, Chaitanya E. Ramesh, Harsha Gowda, Hiranjith G.H., Vedam L. Ramprasad, Somasekar Seshagiri
MedGenome specializes in processing challenging samples including FFPE and low-quality input material. Our analysis includes comprehensive report with rich visualizations identifying all types of relevant DNA and RNA variants.
ASHG 2023

VaRTK – An accurate machine learning model trained on clinically curated variants to predict the variant pathogenicity score

Ravi Gupta, Manju Lakshmi, Charugulla Sai Yuva Sandeep, S. G. Thenral, Sandhya Nair, Anurag Gupta, Thiramsetti Sattibabu, Amit Parhar, Tamanna Golani, Sudarshana J. Pai, Tavleen Bajwa, Sakthivel Murugan S. M., Ramprasad V. L.
Identifying and prioritizing the disease causing variants from thousands of variants that are called during a whole genome and exome sequencing analysis is a time consuming and manual task. Pathogenicity based ranking of variants greatly improves the speed of report generation, in turn increasing the diagnostic yield.

MedGenome Inc. Broadens Single Cell Transcriptome and Epigenome Profiling: From Tissues to single nuclei RNA (snRNA) Sequencing and Data Analysis

Neha Verma, Kushal Suryamohan, Derek Vargas, Ekkirala Chaitanya Ramesh
Single-cell transcriptomics has revolutionized genomics and is now an integral part of therapeutics and diagnostics research. Single cell RNA sequencing (scRNA-seq) enables the analysis of gene expression at single cell resolution via droplet-based cell capture methods that rely on microfluidic instruments such as those developed by 10x genomics.
SLAS 2020

Multiple Platforms for Single Cell Genomics to Enable Biomarker Discovery in Immunotherapy

Ankita Das, Jing Wang, Kayla Lee, Derek Vargas, Gavin Washburn, Niyati Thosani, Vasumathi Kode, Nitin Mandloi, Angelica Lavallee, Amit Chaudhuri and Papia Chakraborty
Single cell genomic approaches can provide valuable insights into the complexity and heterogeneity of the cell types in the context of a tissue or tumor. However, challenges with the preparation of single cell suspensions, good cell viability and efficiently capturing diverse cell types in a mix via appropriate cell capture methods can override the utility of the approaches.